Enterprise Value to EBITDA Multiple ratio Analysis of Tarsus Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-8759.54
Period Ending - Dec-22
Very Poor EV to EBITDA
-13.07
Growth
-66914.26 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-6.26
EV to EBITDA Analysis of Tarsus Pharmaceuticals Inc
| EV to EBITDA Ratio of TARS drastically fell by -66914.26 % this year. |
| EV to EBITDA Ratio with value of -0.909 was highest in Year Dec-20 in last Five Years. |
| EV to EBITDA Ratio with value of -8759.54 was lowest in Year Dec-23 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -8759.54 is lower than Average EV to EBITDA of -2124.45 in last five years. |
Other EV to EBITDA Related Info of TARS that may interest you.
Tarsus Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| TARS | 30.98 | 33.14 | 6.52 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Tarsus Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|
| EV to EBITDA | -8759.54 | -13.07 | -1832.54 | -0.909 | -16.16 | -99.01 |
| Change | -66914.26 % | 99.29 % | -201472.63 % | 94.38 % | 83.68 % |
FY Chart of Enterprise Value to EBITDA Multiple of Tarsus Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)